AstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live 23 months longer than...
Medicine
Two years ago, a drug called Enhertu changed the way doctors thought about treating an aggressive form of breast cancer,...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology...
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what...
Food and Drug Administration scientists have reservations about a potential new treatment for post-traumatic stress disorder that’s currently up for...
People with chronic myeloid leukemia, a simmering cancer of the bone marrow, are often treated with one of several targeted...
Dive Brief: Immunovant told investors Wednesday that it’s shifting resources to focus on a less advanced experimental autoimmune disease treatment...
Otsuka America, a subsidiary of the Japanese drug and device maker, this month launched a new company focused on digital...
Dive Brief: Gameto, a biotechnology company developing new treatments for fertility, has raised $33 million in venture capital funding to...
Dive Brief: Agios Pharmaceuticals has agreed to sell to Royalty Pharma rights to royalties on a brain cancer drug it...